Symbol="BEAM"
AssetType="Common Stock"
Name="Beam TherapeuticsÂ Inc"
Description="Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1745999"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="26 LANDSDOWNE STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2426765000"
EBITDA="-345700000"
PERatio="None"
PEGRatio="None"
BookValue="10.55"
DividendPerShare="0"
DividendYield="0"
EPS="-4.45"
RevenuePerShareTTM="1.082"
ProfitMargin="0"
OperatingMarginTTM="-4.709"
ReturnOnAssetsTTM="-0.162"
ReturnOnEquityTTM="-0.361"
RevenueTTM="76696000"
GrossProfitTTM="-250674000"
DilutedEPSTTM="-4.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.871"
AnalystTargetPrice="67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="32.42"
PriceToBookRatio="4.426"
EVToRevenue="24.39"
EVToEBITDA="-7.47"
Beta="1.627"
num_52WeekHigh="73.27"
num_52WeekLow="28.62"
num_50DayMovingAverage="32.96"
num_200DayMovingAverage="39.48"
SharesOutstanding="76218000"
DividendDate="None"
ExDividendDate="None"
symbol="BEAM"
open="31.13"
high="31.27"
low="30.35"
price="30.41"
volume="690867.00"
latest_trading_day="2023-07-06"
previous_close="31.84"
change="-1.43"
change_percent="-4.4912%"
aroon_positive_momentum_days="21"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="892250"
Change_recent_avg="-0.08"
Delta_recent_avg="1.66"
Variance_recent_avg="0.83"
Change_ratio_recent_avg="-0.27"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="1091"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_negative_thumbnail_id_2="1148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_neutral_thumbnail_id_1="543"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="686"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_positive_thumbnail_id_2="651"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
